This medicine inhibits DPP-4, an enzyme degrading incretin hormones that maintain a constant level of blood glucose, to stimulate insulin secretion when blood glucose is elevated and thereby to improve blood glucose control. It is usually used to treat type II diabetes mellitus.
Medicince introduction including background, function, caution, etc.
Indication Trelagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Side Effects Itching, rashes, hives, shortness of breath Mechanism Of Action Wedica is a once-weekly dipeptidyl peptidase-IV (DPP-4) inhibitor. It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones* that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels